Web Content Viewer

Assessment of the in-use stability of the PRRS virus of two different commercial PRRS MLV after reconstitution with PPV and SE vaccines

Beranda
Pengetahuan
Assessment of the in-use stability of the PRRS virus of two different commercial PRRS MLV after reconstitution with PPV and SE vaccines

Assessment of the in-use stability of the PRRS virus of two different commercial PRRS MLV after reconstitution with PPV and SE vaccines

The purpose of this study was to assess the in-use stability of the UNISTRAIN® PRRS vaccine after it has been reconstituted with ERYSENG® PARVO in comparison with the in-use stability of another European commercial PRRS MLV reconstituted with the SE and PPV vaccine from the same manufacturer.

Tentang artikel ini

Muncul di

IPVS & ESPHM Congress, 2016

Penulis

Miranda, J.; Camprodon, A.; Fenech, M.;

Ringkasan

One of the most important factors for obtaining registration for
the combined use of a MLV PRRS vaccine and SE and PPV
vaccine is to ensure that the PRRS virus is kept alive after the
vaccines are mixed together. The results of the study
demonstrated that the viability of the PRRS virus after mixing
UNISTRAIN® PRRS and ERYSENG® PARVO can be guaranteed
for 2 hours after reconstitution, unlike the non-registered
combination of the other commercial MLV combined with the
SE and PPV vaccine from the same manufacturer.